Primary hyperparathyroidism: When to observe and when to operate

Endocrinology and Metabolism Clinics of North America

Volumn 29, Issue 3, 2000, Pages 465-478

  Bilezikian, John P ^b  

^a College of Physicians and Surgeons ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; VITAMIN D;

CONTROLLED STUDY; DECISION MAKING; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MENOPAUSE; MORPHOMETRICS; OSTEOPENIA; PARATHYROIDECTOMY; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TREATMENT INDICATION; VITAMIN D DEFICIENCY;

EID: 0033820329     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70146-8     Document Type: Article

References (56)

1. Hyperparathyroidism and paranoid psychosis: Case report and review of the literature
2. Vitamin D and the parathyroid
3. Hyperparathyroidism and pancreatitis: Chance or a causal association
4. Pseudogout following parathyroidectomy
5. Primary hyperparathyroidism in women: New York and Beijing. A tale of two cities
6. Clinical presentation of primary hyperparathyroidism
7. Characterization and evaluation of asymptomatic primary hyperparathyroidism
8. Blood pressure in patients with primary hyperparathyroidism before and after parathyroidectomy
9. Neurobehavioral symptoms in mild primary hyperparathyroidism: Related to hypercalcemia but not improved by parathyroidectomy
10. Vitamin D insufficiency in adults and the elderly
11. The story of hyperparathyroidism at the Massachusetts General Hospital
12. Back pain and vertebral crush fractures: An unemphasized mode of presentation for primary hyperparathyroidism
13. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism
14. Parathyroid hypertension: A reversible disorder
15. Hiperparatiroidismo primario: Dramatico incremento de la masa ostea post paratiroidectomia
16. Vitamin D parathyroid hormone and calcium: A complex regulatory network
17. Acute primary hyperparathyroidism
18. Myopathy in primary hyperparathyroidism: Observations in three patients
19. Pseudogout as a clue and complication in primary hyperparathyroidism
20. Primary hyperparathyroidism: Incidence, morbidity, and economic impact in a community
21. Primary hyperparathyroidism in patients with organic brain syndrome
22. Psychiatric morbidity in primary hyperparathyroidism
23. Primary hyperparathyroidism and the risk of fracture: A population-based study
24. Nephrolithiasis in primary hyperparathyroidism
25. What is the clinical significance of bone loss in primary hyperparathyroidism
26. Marked improvement in bone mass after parathyroidectomy in osteititis fibrosa cystica
27. The risk of hip fractures in patients with primary hyperparathyroidism: A population-based cohort study with a follow-up of 19 years
28. Primary hyperparathyroidism and peptic ulcer disease
29. Longitudinal studies of mild primary hyperparathyroidism
30. Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism
31. Anemia in primary hyperparathyroidism, renewed interest in an old observation
32. Sestamibi: Opening a new era of parathyroid surgical procedures
33. Primary hyperparathyroidism: Changes in the pattern of clinical presentation
34. Consensus development conference statement on primary hyperparathyroidism
35. Bone structure in postmenopausal hyperparathyroid, osteoporotic and normal women
36. Maintenance of cancellous bone connectivity in primary hyperparathyroidism: Trabecular and strut analysis
37. The histomorphometry of bone in primary hyperparathyroidism: Preservation of cancellous bone structure
38. Serum levels of intact parathyroid hormone and alkaline phosphates correlate with cortical and trabecular bone loss in primary hyperparathyroidism
39. Arterial hypertension and primary hyperparathyroidism
40. Reversible hypertension in primary hyperparathyroidism: Pre- and postoperative blood pressure in 75 cases
41. Therapeutic controversies in primary hyperparathyroidism
42. NIH Consensus Conference Guidelines for surgery in asymptomatic primary hyperparathyroidism
43. Primary hyperparathyroidism
44. Increased bone mineral density following parathyroidectomy in primary hyperparathyroidism
45. Vertebral osteopenia: A new indication for surgery in primary hyperparathyroidism
46. Skeletal disease in primary hyperparathyroidism
47. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism
48. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery
49. Psychologic symptoms before and after parathyroid surgery
50. Primary hyperparathyroidism: Incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy
51. Rapid improvement of osteoporosis following parathyroidectomy in a premenopausal woman with acute primary hyperparathyroidism
52. Treatment of primary hyperparathyroidism
53. Diagnostic features of muscular syndrome resulting from hyperparathyroidism, osteomalacia owing to renal tubular acidosis and perhaps to related disorders of calcium metabolism
54. Mild asymptomatic primary hyperparathyroidism is no a risk factor for vertebral fractures
55. Vitamin D deficiency and primary hyperparathyroidism